
March 13, 2018 Manufacturing and Production, Research and Development Adaxis, AstraZeneca, Imfinzi, biotech, drugs, immunotherapy, pharma, pharmaceutical

March 13, 2018 Manufacturing and Production, Research and Development Anthera, Eli Lilly, Sollpura, pharma, trial failure

March 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug safety, pharma, pharmacovigilance

March 12, 2018 Research and Development, Sales and Marketing AstraZeneca, Brilinta, heart attack

March 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Martin Shkreli, pharma

March 12, 2018 Research and Development, Sales and Marketing Regeneron, Sanofi, pharma, praluent

March 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Biogen, Celgene, EMA, Gilead, HIV, Herceptin, Japan, NHS, Ontruzant, Sanofi, opioid crisis, opioids, pharma, real world data, top ten, zinbryta

March 9, 2018 Medical Communications, Research and Development Belgium, Cancer, Convert pharma, chemotherapy, pharma

March 9, 2018 Medical Communications, Research and Development VBL, VBL Therapeutics, glioblastoma, pharma, trial failure

March 8, 2018 Medical Communications, Research and Development US, opioid crisis, opioids, pharma

March 8, 2018 Research and Development, Sales and Marketing Evotec, Sanofi, infectious disease, infective disease, pharma

March 7, 2018 Research and Development, Sales and Marketing HIV, Theratechnologies, Trogarzo, pharma

March 7, 2018 Research and Development, Sales and Marketing Sanofi, pharma

March 7, 2018 Research and Development India, diabetes, pharma, regulatory, type 2 diabetes

March 7, 2018 Research and Development, Sales and Marketing Japan, generics, keytruda, opdivo, pharma